- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
EHRs to Redefine the Role of Doctor
Office visits are likely to decrease as both physician and patient rely more on digital tools, study concludes.
Researchers at the Johns Hopkins Bloomberg School of Public Health and The Commonwealth Fund have concluded that electronic health record systems and other digital tools are likely to curb the demand for physicians in the future.
Based on their analysis of recent trends in digital health care and a review of the scientific literature, the authors conclude that patients’ future use of physician services will change dramatically as electronic health records and consumer e-health “apps” proliferate. The findings appear in the issue of the journal Health Affairs.
The results of our study are important because they provide a forward looking snapshot of how health IT will profoundly impact the American health care workforce over the next decade or two,” said the study’s lead author Jonathan Weiner, professor of Health Policy and Management at the Johns Hopkins Bloomberg School and director of the Center for Population Health Information Technology.
Read the full stoy here: http://bit.ly/1euNU6e
Source: Healthcare IT News
Lower Diagnostic Error Rates Found Among Hospitalized Patients During Care Transitions
October 21st 2024Examining care transitions in hospitalized patients revealed lower diagnostic error rates compared with traditional methods, highlighting the effectiveness of this approach in identifying diagnostic challenges.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
FDA Approves Optune Lua Device in NSCLC
October 16th 2024Optune Lua creates tumor-treating fields to disrupt cancer cell division, and it is used in conjunction with PD-1/PD-L1 inhibitors or docetaxel to treat metastatic non–small cell lung cancer (NSCLC) that has not responded to platinum-based treatment.
Read More
